{
    "nct_id": "NCT06387355",
    "official_title": "Diagnosis and Treatment of Coronary Artery Disease in Severe Peripheral Artery Disease After Lower Extremity Revascularization",
    "inclusion_criteria": "* Male or female 50 to 85\n* Severe intermittent claudication with ABI < 0.6 or monophasic waveform if non-compressible and TBI < 0.6\n* Chronic limb threatening ischemia (CLTI) with pain at rest (Rutherford Category 4) with ABI < 0.5 or TBI < 0.6\n* CLTI with minor tissue loss (Rutherford Category 5) with ABI < 0.5 or TBI < 0.6\n* Completed Lower Extremity Revascularization and enrolled within 45 days\n* The patient or legal representative will provide informed written consent\n* The patient has a life expectancy of at least 1 year\nHealthy volunteers allowed\nMust have minimum age of 50 Years\nMust have maximum age of 85 Years",
    "exclusion_criteria": "* Major tissue loss of the ischemic limb (Rutherford Category 6)\n* Uncompensated congestive heart failure (NYHA class IV)\n* Myocardial infarction or stroke within the past 90 days\n* Prior coronary artery bypass graft (CABG) revascularization surgery\n* Prior percutaneous coronary intervention (PCI) with angioplasty or stenting\n* Presence of a pacemaker\n* Congestive heart failure with Ejection Fraction < 30%\n* Elevated liver function tests more than twice the upper limit of normal\n* Severe Chronic renal disease (Glomerular Filtration Rate, GFR < 30) or on hemodialysis\n* Pregnancy, Human Immunodeficiency Virus, or organ transplant recipients\n* Current malignancy or malignancy within the last two years unless the treating oncologic physician provides prognosis of an anticipated 2- year survival (i.e., adequately treated non-melanoma skin cancer or adequately treated prostate cancer without metastatic disease)\n* Any condition the review panel determines would make the patient unsuitable for participation in the study",
    "miscellaneous_criteria": ""
}